ST. LOUIS, Nov. 14, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) today announced its intention to release its 2017 financial guidance on Wednesday, December 14, 2016, via press release before the market opens, followed by a conference call to discuss the 2017 financial guidance at 9:00 a.m. Eastern Time (8:00 a.m. Central Time) on Wednesday, December 14, 2016. The conference call will feature remarks by Tim Wentworth, CEO and President and Eric Slusser, CFO.

The call is being broadcast and can be accessed at the Investor Information section of Express Scripts' website at www.express-scripts.com/corporate. RealPlayer or Windows Media Player is needed to listen to the broadcast and free downloads of these players are available at the broadcast site.

Following the conference call, the webcast will remain available on the Investor Information section of Express Scripts' website for 90 days.

About Express Scripts

Express Scripts puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/express-scripts-holding-company-announces-2017-financial-guidance-conference-call-300362354.html

SOURCE Express Scripts Holding Company

Eric Slusser, Chief Financial Officer, Ben Bier, Vice President Investor Relations, (314) 810-3115, investor.relations@express-scripts.com

Express Scripts Holding Company published this content on 14 November 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 14 November 2016 19:43:02 UTC.

Original documenthttp://phx.corporate-ir.net/phoenix.zhtml?c=69641&p=irol-newsArticle&ID=2222229

Public permalinkhttp://www.publicnow.com/view/D970F3772CC1EA1DEF8390178BF51DA53915DC40